Press-release for stocks publishing date 2021 - 04

Prices are updated after-hours

Current COVID-19 Vaccines are Great. Can They be Better?
Published: 2021-04-06 (Crawled : 18:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.3% 7.2M

| -8.76% | O: 0.4% H: 0.27% C: -0.42%
SNY | News | $47.125 1.78% 1.75% 2.1M

| -7.78% | O: -0.98% H: 1.11% C: 0.2%
covid vaccine covid-19

Positive Phase 1/2 Results for Valneva's Inactivated COVID-19 Vaccine Candidate Using Dynavax's CpG 1018™ Adjuvant
Published: 2021-04-06 (Crawled : 13:35) - biospace.com/
DVAX | $11.84 0.34% 0.34% 2.6M

| 20.33% | O: 2.13% H: 4.49% C: 0.7%
covid phase 1 positive results vaccine phase 3 phase 2

| -8.76% | O: 0.4% H: 0.27% C: -0.42%
CTLT | $56.05 1.03% 0.0% 1.8M

| -47.0% | O: 0.36% H: 1.85% C: 0.85%
MRNA | News S | $104.46 3.01% 2.94% 2.6M

| -19.59% | O: 0.15% H: 6.26% C: 2.63%
covid collaboration vaccine

GTMRx Institute Launches National Task Force to Build Vaccine Confidence
Published: 2021-04-06 (Crawled : 12:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M

| -8.76% | O: 0.4% H: 0.27% C: -0.42%
vaccine

Bavarian Nordic Receives Order to Manufacture Additional Ebola Vaccines
Published: 2021-04-06 (Crawled : 10:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M